• 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br Williams CA Fernandez Alonso R Wang J Toth R


    [62] Williams CA, Fernandez-Alonso R, Wang J, Toth R, Gray NS, Findlay GM. Erk5 is a key regulator of naive-primed transition and embryonic stem cell identity. Cell Rep 2016;16:1820–8. [63] Gao C, Huang L, Long Y, Zheng J, Yang J, Pu S, Xie L. Y-39983, a selective Rho-kinase inhibitor, attenuates experimental au-toimmune encephalomyelitis via inhibition of demyelination. Neuroimmunomodulation 2013;20:334–40.
    [65] Meng X, Matlawska-Wasowska K, Girodon F, Mazel T, Willman CL, Atlas S, Chen IM, Harvey RC, Hunger SP, Ness SA, Winter SS, Wilson BS. GSI-I (Z-LLNle-CHO) in-hibits gamma-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia. Leukemia 2011;25:1135–46.
    [69] Peters GJ, Backus HH, Freemantle S, van Triest B, Codac-ci-Pisanelli G, van der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S, McLeod HL, Bloemena E, Meijer S, Jansen G, van Groeningen CJ, Pinedo HM. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta 2002;1587:194–205.
    [70] Diop-Bove NK, Wu J, Zhao R, Locker J, Goldman ID. Hy-permethylation of the human proton-coupled folate trans-porter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line. Mol Cancer Ther 2009;8:2424–31.
    [71] Yan L, Otterness DM, Weinshilboum RM. Human nicoti-namide N-methyltransferase pharmacogenetics: gene se-quence analysis and promoter characterization. Pharmacoge-netics 1999;9:307–16.  37
    [72] Zhang J, Wang Y, Li G, Yu H, Xie X. Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer MG-132 via the mitochondria-mediated pathway. PLoS One 2014;9:e89202.
    [73] Rini J, Szumlanski C, Guerciolini R, Weinshilboum RM. Human liver nicotinamide N-methyltransferase: ion-pairing radiochem-ical assay, biochemical properties and individual variation. Clin Chim Acta 1990;186:359–74.
    [75] Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epige-netic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol 2013;9:300–6.
    [76] van Haren MJ, Taig R, Kuppens J, Sastre Torano J, Moret EE, Parsons RB, Sartini D, Emanuelli M, Martin NI. In-hibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state. Org Biomol Chem 2017;15:6656–67.
    [77] Wong CC, Qian Y, Yu J. Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic ap-proaches. Oncogene 2017;36:3359–74.
    [78] Murray B, Antonyuk SV, Marina A, Van Liempd SM, Lu SC, Mato JM, Hasnain SS, Rojas AL. Structure and function study of the complex that synthesizes S-adenosylmethionine. IUCrJ 2014;1:240–9.
    [79] Shackelford RE, Vora M, Mayhall K, Cotelingam J. ALK-rear-rangements and testing methods in non-small cell lung cancer: a review. Genes Cancer 2014;5:1–14.
    [80] Kernagis DN, Hall AH, Datto MB. Genes with bimodal expres-sion are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival. J Mol Diagn 2012;14:214–22.
    [81] Hellwig B, Hengstler JG, Schmidt M, Gehrmann MC, Schor-mann W, Rahnenfuhrer J. Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes. BMC Bioin-form 2010;11:276.
    [82] Huang F, Reeves K, Han X, Fairchild C, Platero S, Wong TW, Lee F, Shaw P, Clark E. Identification of candidate molecu-lar markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. Cancer Res 2007;67:2226–38. [83] Chen C, Wang X, Huang X, Yong H, Shen J, Tang Q, Zhu J, Ni J, Feng Z. Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma. Am J Can-cer Res 2016;6:649–63.
    [84] Teng YW, Mehedint MG, Garrow TA, Zeisel SH. Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J Biol Chem 2011;286:36258–67.
    [85] Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 2011;34:75–81. [86] Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Nat-sukawa S, Shaura K, Koizumi Y, Kasuga Y, Yoshimura K, Yoshida T, Tsugane S. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 2005;53:42–50.
    [87] Shin M, Bryant JD, Momb J, Appling DR. Mitochondrial MTHFD2L is a dual redox cofactor-specific methylenete-trahydrofolate dehydrogenase/methenyltetrahydrofolate cyclo-hydrolase expressed in both adult and embryonic tissues. J Biol Chem 2014;289:15507–17.